Theme
Biotech '24: Pharma/Therapeutics☆
ALT-30.28%7.7%
ARQT+22.94%7.7%
ARWR+91.03%7.7%
AVXL-80.56%7.7%
BCRX+12.14%7.7%
BHVN-11.19%7.7%
HALO+52.57%7.7%
KNSA+96.61%7.7%
KROS-28.72%7.7%
KYMR+91.77%7.7%
SPRY-60.12%7.7%
TERN+2.86%7.7%
VRDN-8.58%7.7%
As of Oct 2, 2026, 9:55 PM ET
Biotech '24: Pharma/Therapeutics Constituents
Altimmune, Inc.ALT | 7.7% | -0.91% | -19.65% | -16.46% | -0.72% | -24.10% | -36.43% | -42.68% | -30.28% | -55.53% | -77.11% | $531.9M |
Anavex Life Sciences Corp.AVXL | 7.7% | -3.70% | -28.14% | -38.58% | -6.08% | -50.14% | -59.93% | -79.26% | -80.56% | -67.50% | -89.86% | $168.7M |
Arcutis Biotherapeutics, Inc.ARQT | 7.7% | -0.51% | -5.96% | 9.54% | 3.30% | -10.04% | -3.13% | 57.38% | 22.94% | 147.27% | -0.20% | $3.15B |
Arrowhead Pharmaceuticals, Inc.ARWR | 7.7% | -0.93% | -8.02% | -22.58% | 2.01% | -0.44% | 4.46% | 420.84% | 91.03% | 240.53% | 2.54% | $9.04B |
ARS Pharmaceuticals, Inc.SPRY | 7.7% | -1.21% | -8.48% | -29.55% | -0.49% | -64.81% | -55.82% | -68.58% | -60.12% | -70.93% | -65.12% | $404.2M |
BioCryst Pharmaceuticals, Inc.BCRX | 7.7% | 0.62% | -6.38% | -19.17% | 1.23% | 5.38% | -6.06% | 10.63% | 12.14% | 10.11% | -40.50% | $2.08B |
Biohaven Ltd.BHVN | 7.7% | -2.05% | -7.24% | -12.21% | 4.83% | 22.01% | 19.57% | -41.83% | -11.19% | -72.41% | 76.30% | $1.94B |
Halozyme Therapeutics, Inc.HALO | 7.7% | 2.73% | -4.99% | -0.26% | 2.28% | 62.53% | 57.31% | 73.56% | 52.57% | 81.80% | 169.60% | $13.03B |
Keros Therapeutics, Inc.KROS | 7.7% | 0.89% | -5.33% | -1.11% | -1.38% | -45.46% | -21.74% | 10.61% | -28.72% | -81.04% | -71.54% | $225.2M |
Kiniksa Pharmaceuticals International, plcKNSA | 7.7% | 0.76% | -5.55% | -7.79% | -2.06% | 78.59% | 65.59% | 237.16% | 96.61% | 212.02% | 560.19% | $5.78B |
Kymera Therapeutics, Inc.KYMR | 7.7% | -2.48% | -12.02% | -9.47% | -2.48% | 38.02% | 17.56% | 307.40% | 91.77% | 147.39% | 78.33% | $8.83B |
Terns Pharmaceuticals, Inc.TERN | 7.7% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 231.73% | 2.86% | 0.73% | -23.02% | $744.0M |
Viridian Therapeutics, Inc.VRDN | 7.7% | 2.16% | -12.30% | -14.84% | 2.16% | -37.66% | -33.97% | 48.43% | -8.58% | -18.76% | 17.43% | $2.20B |
| Theme return | — | -0.36% | -9.54% | -12.58% | 0.46% | -1.68% | -3.92% | 64.51% | 10.96% | 29.83% | 111.14% | — |
| Average | 7.7% | -0.36% | -9.54% | -12.50% | 0.20% | -2.01% | -4.05% | 89.65% | 11.57% | 36.44% | 41.31% | $3.70B |
| Median | 7.7% | -0.51% | -7.24% | -12.21% | 0.00% | -0.44% | -3.13% | 48.43% | 2.86% | 0.73% | -0.20% | $2.08B |
| Std Dev | 0.0% | 1.75% | 7.01% | 12.68% | 2.76% | 41.95% | 37.00% | 152.64% | 55.32% | 111.14% | 166.00% | $4.01B |
| Min | 7.7% | -3.70% | -28.14% | -38.58% | -6.08% | -64.81% | -59.93% | -79.26% | -80.56% | -81.04% | -89.86% | $168.7M |
| Max | 7.7% | 2.73% | 0.00% | 9.54% | 4.83% | 78.59% | 65.59% | 420.84% | 96.61% | 240.53% | 560.19% | $13.03B |
| % Positive Tickers | 38.46% | 0.00% | 7.69% | 46.15% | 38.46% | 38.46% | 69.23% | 53.85% | 53.85% | 46.15% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort